Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pertuzumab, Trastuzumab, and Nab-Paclitaxel in HER-2 Positive Advanced Breast Cancer
NCT01730833Phase 2Completed
- Sponsor
- City of Hope
- Start
- Jul 2013
- Primary completion
- Jan 2021
- Modality
- Antibody Conjugates, Polymer-based Nanoparticles, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of pertuzumab, trastuzumab, nab-paclitaxel in breast cancer, sponsored by City of Hope. Started Jul 2013; status: completed.
02
Drugs
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT01730833.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01730833.